Ledger.Open graph →
SEC Form D · Amendment · filed June 13, 2016

Advantagene, Inc

Offering
$35.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUBURNDALE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Estuardo Aguilar-Cordova · Auburndale, MAExec · DirectorGlenn C. Mattes · Auburndale, MADirectorFred C. Mermelstein · Auburndale, MADirectorUdi C. Merav · Auburndale, MADirectorMitchell C. Finer · Auburndale, MADirectorAlan C. Smith · Auburndale, MADirectorStephen C. Rocamboli · Auburndale, MAExecLaura Aguilar · Auburndale, MAExecKenneth Luginbuhl · Ellington, CTExec · DirectorCyrus S. Driver · VANCOUVER, British Columbia, CanadaDirectorArlo Hoffman · Ellington, CTDirectorSeth Bahler · Tolland, CTExecMaria Milagros A. Paredes · VANCOUVER, British Columbia, CanadaDirectorRick Metzger · Morris, MNDirectorMatthew A. Blanchard · San Diego, CAExec · DirectorRobert S. Wasylyshyn · VANCOUVER, British Columbia, CanadaExec · DirectorRobert E. Weisskoff · Berkeley, CADirectorAndrew Ervin · Boston, MAExec · DirectorAlberto S. Montoya · VANCOUVER, British Columbia, CanadaDirectorRachel E. Haurwitz · Berkeley, CADirectorMats Lederhausen · Boston, MADirectorMarion A. Mcgrath · VANCOUVER, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗